−20.5
AN2 Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−33.5
FY23:
−53.3
FY24:
−49.3
FY25:
−29.8
Change from FY21 to FY25
millions USD
FY21:
−50.0
FY22:
−21.8
FY23:
−43.3
FY24:
54.6
FY25:
28.3
Change from FY21 to FY25
millions USD
FY21:
78.5
FY22:
70.4
FY23:
85.0
FY24:
0.37
FY25:
0.11
millions USD
FY21:
8.03
FY22:
15.1
FY23:
−11.6
FY24:
5.70
FY25:
−1.41
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
−29.8
All amounts in millions USD